Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients

Journal of Clinical Microbiology

Volumn 37, Issue 6, 1999, Pages 1876-1880

  Wisplinghoff, H ^a   Reinert, R R ^b   Cornely, O ^a   Seifert, H ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; SPARFLOXACIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; CANCER PATIENT; CHILD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MINIMUM INHIBITORY CONCENTRATION; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS ORALIS; STREPTOCOCCUS SALIVARIUS;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS MITIS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS SALIVARIUS;

EID: 0032951608     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.6.1876-1880.1999     Document Type: Article

References (31)

1. Alcaide, F., J. Linares, R. Pallares, J. Carratalá, M. A. Benitez, F. Gudiol, and R. Martin. 1995. In vitro activities of 22 β-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob. Agents Chemother. 39:2243-2247.
2. Alcaide, F., J. Carratalá, J. Linares, F. Gudiol, and R. Martin. 1996. In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients. Antimicrob. Agents Chemother. 40:2117-2120.
3. Awada, G., P. van der Auwera, F. Meunier, D. Daneau, and J. Klastersky. 1992. Streptococcal and enterococcal bacteremia in patients with cancer. Clin. Infect. Dis. 15:33-48.
4. Bilgrami, S., J. M. Feingold, D. Dorsky, R. L. Edwards, J. Clive, and P. J. Tutschka. 1998. Streptococcus viridans bacteremia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 21:591-595.
5. Bochud, P.-Y., P. Eggiman, T. Calandra, G. Van Melle, L. Saghafi, and P. Francioli. 1994. Bacteremia due to viridans Streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin. Infect. Dis. 18:25-31.
6. Bochud, P.-Y., A. Cometta, and P. Francioli. 1997. Virulent infections caused by alpha-haemolytic streptococci in cancer patients and their management. Curr. Opin. Infect. Dis. 10:422-430.
7. Burden, A. D., B. A. Oppenheim, D. Crowther, A. Howell, G. R. Morgenstern, J. H. Scarffe, and N. Thatcher. 1991. Viridans streptococcal bacteremia in patients with haematological and solid malignancies. Eur. J. Cancer 27:409-411.
8. Carratalá, J., F. Alcaide, A. Fernández-Sevilla, X. Corbella, J. Linares, and F. Gudiol. 1995. Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer. Clin. Infect. Dis. 20:1169-1173.
9. Cohen, J., J. P. Donnelly, A. M. Warsley, D. Catovsky, J. M. Goldman, and D. A. Galton. 1983. Septicemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet ii:1452-1454.
10. Doern, G. V., M. J. Ferraro, A. B. Brueggemann, and K. L. Ruoff. 1996. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob. Agents Chemother. 40:891-894.
11. Donelly, J. P., E. C. Dompeling, J. F. Meis, and B. E. De Pauw. 1995. Bacteremia due to oral viridans streptococci in neutropenic patients with cancer: cytostatics are a more important risk factor than antibacterial prophylaxis. Clin. Infect. Dis. 20:469-470.
12. Elting, L. S., G. P. Bodey, and B. H. Keefe. 1992. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin. Infect. Dis. 14:1201-1207.
13. Garner, J. S., W. R. Jarvis, T. G. Emori, T. C. Horan, and J. M. Hughes. 1988. CDC definitions for nosocomial infections. Am. J. Infect. Control 16:128-140.
14. González-Barca, E., A. Fernández-Sevilla, J. Carratalá, A. Granena, and F. Gudiol. 1996. Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution. Eur. J. Clin. Microbiol. Infect. Dis. 15:291-296.
15. Grundmann, H. J., K. J. Towner, L. Dijkshoorn, P. Gerner-Smidt, M. Maher, H. Seifert, and M. Vaneechoutte. 1997. Multicenter study using standardized protocols and reagents for evaluation of PCR-fingerprinting reproducibility with Acinetobacter spp. J. Clin. Microbiol. 35:3071-3077.
16. Jacobs, J. A., H. C. Schouten, E. E. Stobberingh, and P. B. Soeters. 1995. Viridans streptococci isolated from the bloodstream. Diagn. Microbiol. In7 fect. Dis. 22:267-273.
17. Kern, W., E. Kurrle, and T. Schmeiser. 1990. Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy: a review of 55 cases. Infection 18:138-145.
18. König, A., R. R. Reinert, and R. Hakenbeck. 1998. Streptococcus mitis with unusually high level resistance to beta-lactam antibiotics. Microb. Drug Resist. 4:45-49.
19. Kremery, V., and J. Trupl. 1995. Bacteremia due to penicillin-resistant Streptococcus viridans in cancer patients, before and after the prophylaxis with penicillin. Lancet 346:1362-1363.
20. Laible, G., B. G. Spratt, and R. Hakenbeck. 1991. Interspecies recombinational events during the evolution of altered PBP 2x genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Mol. Microbiol. 5:1993-2002.
21. Maslow, J. N., A. M. Slutsky, and R. D. Arbeit. 1993. Application of pulsed-field gel electrophoresis to molecular epidemiology, p. 563-572. In D. H. Persing, T. F. Smith, F. C. Tenover, and T. J. White (ed.), Diagnostic molecular microbiology. American Society for Microbiology, Washington, D.C.
22. McWhinney, P. H., S. Patel, R. A. Whiley, J. M. Herdie, S. H. Gillespie, and C. C. Kibbler. 1993. Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans streptococci from neutropenic patients receiving ciprofloxacin. Antimicrob. Agents Chemother. 37:2493-2495.
23. National Committee for Clinical Laboratory Standards. 1997. Performance standard for antimicrobial susceptibility disk susceptibility tests, 6th ed. Approved standard. NCCLS publication no. M2-A6. National Committee for Clinical Laboratory Standards, Villanova, Pa.
24. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard. NCCLS publication no. M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
25. Pfaller, M. A., R. A. Jones, S. A. Marshall, M. B. Edmond, and R. P. Wenzel. 1997. Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The Scope Hospital Study Group. Diagn. Microbiol. Infect. Dis. 4:259-263.
26. Potgieter, E., M. Carmichael, H. J. Koornhof, and L. J. Chalkley. 1992. In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures. Eur. J. Clin. Microbiol. Infect. Dis. 11:543-546.
27. Reinert, R. R., A. Queck, A. Kaufhold, M. Kresken, and R. Lütticken. 1995. Antimicrobial resistance and type distribution of Streptococcus pneumoniae in Germany, 1992-1994. Clin. Infect. Dis. 21:1398-1401.
28. Richard, R., G. A. Del Valle, P. Moreau, N. Milpied, M.-P. Felice, T. Daeschler, J. L. Harousseau, and H. Richet. 1995. Viridans streptococcal bacteremia in patients with neutropenia. Lancet 345:1607-1609.
29. Venditti, M., P. Baiocchi, C. Santini, C. Brandimarte, P. Serra, G. Gentile, C. Girmenia, and P. Martino. 1989. Antimicrobial susceptibilities of Streptococcus species that cause septicemia in neutropenic patients. Antimicrob. Agents Chemother. 33:580-582.
30. Weisman, S. J., F. J. Scoopo, G. M. Johnson, A. J. Altman, and J. J. Quinn. 1990. Septicemia in pediatric oncology patients: the significance of viridans streptococcal infections. J. Clin. Oncol. 8:453-459.
31. Wisplinghoff, H., R. R. Reinert, and H. Seifert. 1998. Molecular epidemiology and antimicrobial susceptibility of viridans group streptococci isolated from neutropenic cancer patients, abstr. K-102, p. 531. In Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.